ANAEROBE 2022: the 16th Biennial Congress of the Anaerobe Society of the Americas (ASA)

项目摘要 厌氧菌是在没有氧气的情况下茁壮成长的细菌，是疾病和健康的主要贡献者。 人类。虽然艰难梭菌是一种严重的传染病威胁，也是医疗保健的主要原因- 除了相关感染，还有许多其他厌氧细菌病原体导致痛苦和死亡。 相反，一些厌氧菌对人体的结构和功能有益。 微生物群，与健康有关。尽管地区性学会专注于厌氧细菌科学 过去曾在国外的特定地点(如英国、日本)、美洲厌氧菌协会 (ASA)是唯一持续活跃的协会，也是唯一总部设在美国的协会，致力于 厌氧菌临床科学。此外，ASA保持着活跃的国际成员资格， 来自31个以上国家的代表出席了2020年双年度大会，这次大会是作为一个虚拟的 计划由于新冠肺炎大流行。协会及其两年一次的大会(成立于年)的长期目标 1992年)的目标是通过研究厌氧细菌及其环境来促进健康和促进科学进步。 这项提案寻求NIH对厌氧菌2022的支持，这是ASA的第16届两年一度的大会，将是 作为混合会议于2022年7月28日至31日在华盛顿州西雅图举行。第十六届两年一度大会的具体目标 旨在：(1)激发学员对无氧运动的兴趣，促进来自世界各地的无氧运动爱好者之间的联系 学科，并通过学员参与的实质性机会培养牢固的指导关系 包括海报会议，早期职业调查员奖，以及我们关于出版的专题突破会议 由一家主要期刊的编辑领导；(2)促进科学交流，向学员展示如何发散 通过专题辩论鼓励和讨论科学观点；(3)探索土著人民的作用 厌氧菌在促进人类健康中的作用并讨论厌氧菌致病的最新见解 包括艰难梭菌和梭菌；(4)促进方法学进步，加速厌氧菌研究 培养技术、基因操作和模型系统；以及(5)检查最新的临床 厌氧菌感染的管理策略和探索新的作用机制、健康益处和 与临床微生物区系转移相关的监管问题。第十六届双年度大会将实现这一目标 Goal通过70多位国内外科学演讲者和各种 演示文稿格式，包括亲自出席或虚拟出席的选项。在为厌氧菌创建程序时 2022年，组委会将参与者和与会者之间的多样性和包容性列为优先事项。这个 有重点的、协同的计划将鼓励科学家之间真诚的跨学科交流 通常聚集在任何其他会议上。与NIH和NIAID的目标一致，第16届双年度 美国医学会大会提供了一个独特的机会，将世界领先的基础和临床 厌氧细菌科学的研究人员将推进对人类健康具有持久影响的研究。

Project Summary Anaerobes, bacteria that thrive in the absence of oxygen, are major contributors to both disease and health in humans. While Clostridioides difficile is a serious infectious disease threat and a leading cause of healthcare- associated infections, there are many other anaerobic bacterial pathogens that contribute to suffering and death. Conversely, some anaerobes contribute in a beneficial way to the structure and function of the human microbiome and are associated with health. Although regional Societies focused on anaerobe bacterial science have existed in the past in select locales abroad (e.g., Britain, Japan), the Anaerobe Society of the Americas (ASA) is the only continuously active society and the only United States-based Society devoted to the basic and clinical science of anaerobes. Further, the ASA maintains an active international membership, with representation from more than 31 countries at the 2020 Biennial Congress, which was conducted as a virtual program due to the COVID-19 pandemic. The long-term goal of the ASA and its biennial congress (founded in 1992) is to promote health and advance science through the study of anaerobic bacteria and their environments. This proposal seeks NIH support for ANAEROBE 2022, the 16th Biennial Congress of the ASA, which will be hosted as a hybrid meeting from July 28-31, 2022 in Seattle, WA. The specific aims of the 16th Biennial Congress are to: (1) stimulate interest in anaerobes among trainees, promote networking among anaerobists from all disciplines, and foster strong mentoring relationships through substantive opportunities for trainee participation including a poster session, early-career investigator awards, and our featured breakout session on publishing led by an editor of a major journal; (2) facilitate scientific interchange and demonstrate for trainees how divergent opinions in science are encouraged and discussed via a featured debate; (3) explore the roles of indigenous anaerobes in promoting human health and discuss recent insights into disease induction by anaerobic bacteria including C. difficile and Fusobacteria; (4) accelerate anaerobe research by facilitating methodological advances in culture techniques, genetic manipulation, and model systems; and (5) examine up-to-date clinical management strategies for anaerobic infections and probe emerging mechanisms of action, health benefits, and regulatory issues associated with clinical microbiota transfer. The 16th Biennial Congress will accomplish this goal through presentations by more than 70 domestic and international scientific speakers and a variety of presentation formats, including the option to attend in-person or virtually. In creating the program for ANAEROBE 2022, the Organizing Committee has prioritized diversity and inclusion among participants and attendees. The focused, synergistic program will encourage hearty interdisciplinary exchange between scientists who do not generally congregate in any other conference. Consistent with the goals of the NIH and NIAID, the 16th Biennial Congress of the ASA provides a unique opportunity to bring together the world’s leading basic and clinical investigators in anaerobe bacterial science to advance studies with lasting impact on human health.